AR027238A1 - Peptido relacionado a condromodulina-i - Google Patents

Peptido relacionado a condromodulina-i

Info

Publication number
AR027238A1
AR027238A1 ARP010100208A ARP010100208A AR027238A1 AR 027238 A1 AR027238 A1 AR 027238A1 AR P010100208 A ARP010100208 A AR P010100208A AR P010100208 A ARP010100208 A AR P010100208A AR 027238 A1 AR027238 A1 AR 027238A1
Authority
AR
Argentina
Prior art keywords
condromodulin
related peptide
polypeptide
refers
proteinmism
Prior art date
Application number
ARP010100208A
Other languages
English (en)
Spanish (es)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR027238A1 publication Critical patent/AR027238A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP010100208A 2000-01-19 2001-01-18 Peptido relacionado a condromodulina-i AR027238A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17689800P 2000-01-19 2000-01-19
US72431000A 2000-11-28 2000-11-28

Publications (1)

Publication Number Publication Date
AR027238A1 true AR027238A1 (es) 2003-03-19

Family

ID=26872727

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100208A AR027238A1 (es) 2000-01-19 2001-01-18 Peptido relacionado a condromodulina-i

Country Status (7)

Country Link
EP (1) EP1261639A2 (fr)
JP (1) JP2003520590A (fr)
AR (1) AR027238A1 (fr)
AU (1) AU3647701A (fr)
CA (1) CA2398695A1 (fr)
MX (1) MXPA02007119A (fr)
WO (1) WO2001053344A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60044138D1 (de) 1999-09-29 2010-05-20 Teijin Ltd POLYPEPTIDE UND FüR DIESE KODIERENDE GENE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3585180B2 (ja) * 1993-05-11 2004-11-04 三菱化学株式会社 新規なヒトタンパク質およびそれをコードする遺伝子
CA2319089A1 (fr) * 1998-04-09 1999-10-21 Genset S.A. Etiquettes de sequences exprimees (est) des 5' et proteines humaines codees
CA2339043A1 (fr) * 1998-09-01 2000-03-09 Genentech, Inc. Nouveaux pro-polypeptides et sequences correspondantes
AU1622200A (en) * 1998-11-13 2000-06-05 Zymogenetics Inc. Mammalian chondromodulin-like protein
EP1144614A4 (fr) * 1999-01-19 2003-08-06 Human Genome Sciences Inc Proteines humaines secretees (33)
AU2883700A (en) * 1999-06-23 2001-01-09 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU7573000A (en) * 1999-09-01 2001-03-26 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE60044138D1 (de) * 1999-09-29 2010-05-20 Teijin Ltd POLYPEPTIDE UND FüR DIESE KODIERENDE GENE
WO2001048203A1 (fr) * 1999-12-27 2001-07-05 Takeda Chemical Industries, Ltd. Nouvelle proteine et adn associe
JP2001299363A (ja) * 1999-12-27 2001-10-30 Takeda Chem Ind Ltd 新規タンパク質およびそのｄｎａ

Also Published As

Publication number Publication date
WO2001053344A2 (fr) 2001-07-26
AU3647701A (en) 2001-07-31
CA2398695A1 (fr) 2001-07-26
EP1261639A2 (fr) 2002-12-04
WO2001053344A3 (fr) 2002-01-03
MXPA02007119A (es) 2003-04-14
JP2003520590A (ja) 2003-07-08

Similar Documents

Publication Publication Date Title
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
BRPI0416744A (pt) sistemas de expressão de proteìna aperfeiçoados
AR055191A1 (es) Generacion y caracterizacion de anticuerpos terapeuticos derivados de hucal- gold totalmente humanos especificos para el cd38 humano
IL175021A0 (en) Chromatin insulator, its preparation and use in protein expression
BG103091A (en) Shortened soluble receptors of type i & ii of the tumour necrotizing factor
WO2001064835A8 (fr) Nouveaux acides nucleiques et polypeptides
ATE414775T1 (de) Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
NO20032286L (no) Anvendelse av ClyA hemolysin for ekskresjon av proteiner
CL2019003405A1 (es) Péptido asociados a tumor (tumap) aislado; ácido nucleico; vector de expresión; célula huésped recombinante que comprendes el péptido; método para producir el péptido; uso para preparar un medicamento útil rara tratar el cáncer; kit farmacéutico. (divisional solicitud 201702407)
AR067980A1 (es) Peptidos de cdh3 y agentes que los comprenden
ATE473238T1 (de) Tuberkulose vaccine mit verbesserter effizienz
DE69535696D1 (de) Tripeptidyl-aminopeptidase
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
DE69938240D1 (de) Neuer g-protein-gekoppelter rezeptor
DK1157100T3 (da) Oxaloacetathydrolase-defekte svampeværtsceller
DE60118359D1 (de) Humanische pellino-polypeptide
ATE401344T1 (de) T-zellen-epitope in erythropoietin
AR027238A1 (es) Peptido relacionado a condromodulina-i
SG165168A1 (en) New adenoviruses, nucleic acids coding therefor and their use
AR009819A1 (es) Inhibidores de la proteasa proteinicos estabilizados y sus variantes
EP1480998A4 (fr) Intermediaires et procedes destines a fabriquer des analogues d'oxytocine heptapeptide
ATE471382T1 (de) Vac-bac-shuttlevektor-system
PE20190967A1 (es) Aislados modificados de streptomyces fungicidicus y su uso
MX2022013737A (es) Nueva proteina y usos terapeuticos y cosmeticos de la misma.

Legal Events

Date Code Title Description
FB Suspension of granting procedure